Business
Prenetics Announces Preliminary Record Q1 2026 Results with IM8 Revenue Growing Nearly 6x YoY; Company Raises Full-Year 2026 IM8 Revenue Guidance to $190M–$210M
Prenetics records Q1 2026 revenue of $36.0 million with IM8 revenue of $33.8 million, up 23.1% from IM8 revenue of $27.4 million in Q4 2025Raises full-year
About this update from Prenetics Global Limited
[{"type":"text","content":"Prenetics records Q1 2026 revenue of $36.0 million with IM8 revenue of $33.8 million, up 23.1% from IM8 revenue of $27.4 million in Q4 2025Raises full-year 2026 IM8 revenue guidance to $190 million to $210 million (previously $180 million to $200 million)Company projects Q2 2026 revenue of $46 million to $48 million, with IM8 contributing $44 million to $46 million, representing approximately 33% sequential quarterly growth for IM8IM8 announces the launch of 3 new SKUs in Q4 with Hydration, Creatine and Kids’ GummiesPrenetics divests full stake of digital assets for $41.3 million in proceeds, further boosting its cash balancePrenetics executed approximately $19 million of previously announced $40 million share buyback programAppointed consumer supplements finance veteran Brian J. Rosin as Chief Financial Officer of IM8Company to host earnings call on May 14, 2026, at 8:30 a.m. ET and latest investor deck can be found at https://ir.prenetics.com NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (\"Prenetics\" or the \"Company\"), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced preliminary financial results for the first quarter ended March 31, 2026. The Company is furnishing preliminary operating results to provide investors with a timely update on IM8’s continued momentum and Prenetics’ strategic transformation, while the Company completes its customary quarter-end closing procedures and related review processes. These procedures include valuation workstreams principally related to non-cash fair-value measurements associated with the Europa 3PL business disposal-related consideration and outstanding warrants. Following completion of these procedures, the Company expects to provide full financial results for the first quarter ended March 31, 2026. Upon the completion of its customary quarter-end closing procedures and related review processes, the Company expects to report revenue of $36.0 million, gross profit of $23.3 million, loss from operations of $8.9 million, and adjusted EBITDA loss of $5.6 million for the first quarter ended March 31, 2026. Preliminary Operating Results Three Months Ended (Unaudited) March 31, 2026 March 31, 2025 % Change (in million of U.S. dollars) Continuing operations Revenue$36.0 $8.3 334.5%Gross pro...